Tag: Pharma sector

Bullish sentiments for QLT Inc

QLTI – QLT Inc, is a Biotechnology company, engaged in development and commercialization of ocular products.

QLTI – QLT, Inc

Fundamentals Previously closed at 1.43
Day’s high 1.47
Day’s low 1.41
P/E ratio NA
EPS -0.74

 

Analysts opinion After a restructuring bout of several years, and cancelled merger attempts with Auxiliam Pharma and InSite Vision, QLT’s price had dropped 64%. Now, QLT and Aegerion have announced a strategic merger, resulting in a combined company named “Novelion Therepeutics”. Under the merger terms, 1 share of Aegerion will be given in return for 1.0256 shares of QLT. An investor syndicate will be purchasing $22 Million worth QLT stocks at $1.76 per stock. Analyst confidence meter, a proprietary algorithm of Stockal gives75% buy based on analyst ratings.
Sentiments The sentiment index is 200% positive according to Stockal proprietary algorithm.
Social Media Pulse The stock has 50% lower social media chatter than usual.

 

Agios Pharma & Eleven Biotherepeutics driven by sentiments

AGIO – Agios Pharmaceuticals, Inc is a biopharmaceutical company, engaged in the discovery and development of medicines for the treatment of cancer and genetic disorders.

AGIO – Agios Pharmaceuticals, Inc

Fundamentals Previously closed at 50.35
Day’s high 55.96
Day’s low 50.02
P/E ratio NA
EPS -3.62

 

Analysts opinion Agios Pharma announced positive results for its phase 1 Drug AG-348, used to treat anaemia. The stock was upgraded by Canaccord Genuity and J. P Morgan to “Buy”. Analyst confidence meter, a proprietary algorithm of Stockal gives 66% buy based on analyst ratings.
Sentiments AGIO fell, after having gained 8% Pre-Market today. The sentiment index is 100% negative according to Stockal proprietary algorithm.
Social Media Pulse The stock has 10% lower social media chatter than usual.

Continue Reading…